# NCT04162015 (NCT04162015)

> A Study of Nivolumab and Chemotherapy Followed by Surgery for Mesothelioma

No report yet. It can be ordered.

## Registry

- Registry record: https://clinicaltrials.gov/study/NCT04162015
- Phase: PHASE1
- Status: ACTIVE_NOT_RECRUITING
- Sponsor: Memorial Sloan Kettering Cancer Center
- Conditions: Malignant Pleural Mesothelioma
- Interventions: Nivolumab; Pemetrexed; Cisplatin or Carboplatin
- Enrollment: 22
- Primary outcome: number of patients going to operating room for surgical resection

## Commentary we found

- X threads: 3

## Order

Focused, $750, price fixed at order: https://www.erudio.com/contact?report=nct04162015